Organization Overview
Alternative names
aldesleukin (proleukin) (3 trials)
asparaginase (elspar) (2 trials)
autologous hematopoietic cell (1 trial)
bleomycin (blenoxane) (2 trials)
cabazitaxel (jevtana kit) (1 trial)
capecitabine (xeloda) (3 trials)
carboplatin (paraplatin) (8 trials)
cetuximab (erbitux) (2 trials)
cytarabine (cytosar-u) (1 trial)
dacarbazine (dtic-dome) (1 trial)
daunorubicin (cerubidine) (1 trial)
doxorubicin (Doxil) (3 trials)
epirubicin (ellence) (4 trials)
etoposide (vepesid) (10 trials)
everolimus (zortress) (3 trials)
fludarabine (fludara) (2 trials)
interferon alpha-2b (Intron-A) (4 trials)
ipilimumab (yervoy) (3 trials)
medroxyprogesterone (provera) (2 trials)
mercaptopurine (purinethol) (1 trial)
methylprednisolone (medrol) (1 trial)
mitoxantrone (novantrone) (1 trial)
abemaciclib (verzenio) (1 trial)
anastrozole (arimidex) (2 trials)
atezolizumab (tecentriq) (4 trials)
bendamustine (treanda) (1 trial)
bevacizumab (avastin) (4 trials)
cabozantinib (cometriq) (2 trials)
cobimetinib (cotellic) (1 trial)
dactinomycin (cosmegen) (1 trial)
degarelix acetate (firmagon) (1 trial)
desflurane (suprane) (1 trial)
filgrastim (neupogen) (3 trials)
hydroxyurea (hydrea) (1 trial)
ibrutinib (imbruvica) (1 trial)
interferon alpha-2a (roferon-a) (1 trial)
lenalidomide (revlimid) (1 trial)
nilotinib (tasigna) (2 trials)
oxaliplatin (eloxatin) (2 trials)
panitumumab (vectibix) (1 trial)
panobinostat (farydak) (1 trial)
pembrolizumab (keytruda) (5 trials)
pertuzumab (perjeta) (1 trial)
regorafenib (stivarga) (2 trials)
Adenocarcinoma (Phase 3)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 3)
Central Nervous System Neoplasms (Phase 3)
Chondrosarcoma (Phase 2)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 2)
Disease Progression (Phase 2)
Endometrial Neoplasms (Phase 2)
Ependymoma (Phase 3)
Esophageal Neoplasms (Phase 2)
Gastrointestinal Stromal Tumors (Phase 3)
Giant Cell Tumor of Tendon Sheath (Phase 2)
Giant Cell Tumors (Phase 2)
Glioblastoma (Phase 3)
Head and Neck Neoplasms (Phase 2)
Infections (Phase 2)
Intestinal Neoplasms (Phase 2)
Kidney Neoplasms (Phase 3)
Leiomyosarcoma (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid (Phase 2)
Liposarcoma (Phase 2)
Liposarcoma, Myxoid (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphopenia (Phase 2)
Medulloblastoma (Phase 2)
Meningeal Carcinomatosis (Phase 2)
Meningioma (Phase 2)
Meningitis (Phase 2)
Mucositis (Phase 3)
Multiple Myeloma (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 3)
Neoplasms, Fibrous Tissue (Phase 2)
Neoplasms, Germ Cell and Embryonal (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Nervous System Neoplasms (Phase 3)
Neuralgia (Phase 2)
Neuroectodermal Tumors (Phase 2)
Neuroectodermal Tumors, Primitive (Phase 2)
Oropharyngeal Neoplasms (Phase 3)
Osteosarcoma (Phase 2)
Ovarian Neoplasms (Phase 3)
Philadelphia Chromosome (Phase 2)
Prostatic Neoplasms (Phase 3)
Rectal Neoplasms (Phase 3)
Recurrence (Phase 3)
Retinal Neoplasms (Phase 2)
Retinoblastoma (Phase 2)
Rhabdomyosarcoma (Phase 2)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Sarcoma, Synovial (Phase 2)
Solitary Fibrous Tumors (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 3)
Stomach Neoplasms (Phase 2)
Stomatitis (Phase 3)
Synovitis (Phase 2)
Synovitis, Pigmented Villonodular (Phase 2)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
